期刊文献+

伊曲康唑脂质体体外抗真菌作用研究 被引量:3

In Vitro Antifungal Activity of Itraconazole Liposome
原文传递
导出
摘要 目的:研究伊曲康唑脂质体体外抗深部真菌作用。方法:测定伊曲康唑脂质体对白色念珠菌、克柔念珠菌、光滑念珠菌、近平滑念珠菌、热带念珠菌等5种临床常用深部真菌的最小抑菌浓度(MIC)和最小杀菌浓度(MBC),采用平皿菌落计数法进行菌落计数,制备克柔念珠菌、近平滑念珠菌的菌落数-时间曲线,并与伊曲康唑注射液的结果进行比较。结果:与伊曲康唑注射液比较,伊曲康唑脂质体对5种深部真菌的MIC、MBC基本一致,对克柔念珠菌、近平滑念珠菌的菌落数-时间曲线基本一致。结论:伊曲康唑脂质体与伊曲康唑注射液对5种深部真菌具有相似的体外抗真菌作用。 OBJECTIVE:To study the antifungal activity of Itraconazole liposome in vitro.METHODS:The minimal inhibitory concentration(MIC) and the minimal bactericidal concentration(MBC) of Itraconazole liposome against 5 kinds of deep fungus(Candida albicans,Candida krusei,Candida glabrata,Candida parapsilosis,Oidium tropioale) were determined.The number of colony was calculated by plate counting method.Colony number-time curves of Itraconazole liposome against Candida krusei and Candida parapsilosis were measured and compared with that of Itraconazole injections.RESULTS:MIC,MBC and colony number-time curves of Itraconazole liposome against 5 kinds of deep fungus were similar to those of Itraconazole injection in experiments.CONCLUSION:The in vitro antifungal activity of Itraconazole liposome against 5 kinds of deep fungus is similar to that of Itraconazole injection.
出处 《中国药房》 CAS CSCD 北大核心 2010年第41期3869-3871,共3页 China Pharmacy
基金 黑龙江省科技厅重点课题(GB06C307)
关键词 伊曲康唑 脂质体 最小抑菌浓度 最小杀菌浓度 菌落数-时间曲线 Itraconazole Liposomes Minimal inhibitory concentration Minimal bactericidal concentration Colony number-time curves
  • 相关文献

参考文献9

二级参考文献38

  • 1张明宇,尹鸿萍,王旻,周建平.紫外分光光度法测定伊曲康唑注射液的含量[J].江苏药学与临床研究,2005,13(4):13-14. 被引量:5
  • 2钟南山,叶枫.深部真菌感染:新的挑战与展望[J].中华结核和呼吸杂志,2006,29(5):289-290. 被引量:96
  • 3侵袭性肺部真菌感染的诊断标准与治疗原则(草案)[J].中华内科杂志,2006,45(8):697-700. 被引量:869
  • 4Ng A W, Wasan K M, Lopez-Berestetin G. Development posomal polyene antibiotics: an historical perspective [J].J Pharm Sci,2003,6:67. 被引量:1
  • 5Hitchcock C A, Pye G W, Oliver G P, et al. UK-109,496; a novel, wide-spectrum triazol derivative for the treatment of fungal infection: antifungal activity and selectivity in vitro [C]. Washington D C. Microbiology Asf. 35th Intersciences conference on antimicrobial agents and chemotherapy, 1995. 被引量:1
  • 6Groll A H, Piscitelli S C, Walsh T J. Clinical pharmacology of systemic antifungal agents.. A comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development [J]. Adv Pharmacol, 1998,44:343. 被引量:1
  • 7Mora-Duarte J, Betts R, Rotstein C, et al, Comparison of caspofungin and amphotericin B for invasive candidiasis [J]. N Engl J Med,2002,347:2020. 被引量:1
  • 8Verduyn Lunel F M, Meis J F, Voss A. Nosocomial fungal infections: candidemia [J]. Diagn Microbiol Infect Dis,1999,34:213. 被引量:1
  • 9Kullberg B J, Oude Lashot A M. Epidemiology of opportunistic invasive mycoses [J]. Eur J Med Re.s, 2002,7: 183. 被引量:1
  • 10Ellis M. Invasive fungal infections: evolving challenges for diagnosis and therapeutics [J]. Mol Immunol, 2001,38:947. 被引量:1

共引文献123

同被引文献34

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部